Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram

Showing results (201-210 of 24,158) with videos related to

Pageof 2,416
Sort By:
ACS Medicinal Chemistry Letters|November 20, 2024
Bicyclic Ureas as JAK2 Inhibitors for Treating Hematological CancerRam W Sabnis
ACS Medicinal Chemistry Letters|November 20, 2024
Novel Papain-Like Protease Inhibitors for Treating Viral Infections, in Particular Coronavirus InfectionsRam W Sabnis
ACS Medicinal Chemistry Letters|November 20, 2024
Novel Indazole Compounds as PKMYT1 Kinase Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|August 14, 2024
Novel Glucagon-like Peptide 1 Receptor Agonists for Treating Type II DiabetesRam W Sabnis
ACS Medicinal Chemistry Letters|May 15, 2024
Pyrrolidinone Derivatives as NIK Inhibitors for Treating Autoimmune and Inflammatory DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|May 15, 2024
Novel CD73 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|December 18, 2024
Novel Pyrrolidinone Urea Compounds as FPR2 Agonists for Treating Atherosclerosis and Heart FailureRam W Sabnis
ACS Medicinal Chemistry Letters|December 18, 2024
Novel Triazines as NLRP3 Inhibitors for Treating Multiple DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|January 15, 2025
Novel Bicyclic Heterocyclic Compounds as CD73 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|January 15, 2025
Novel 3-Pyrrolidineindole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis and Mental Illnesses Such as Depression and Post-Traumatic Stress DisorderRam W Sabnis
Pageof 2,416

Showing results (201-210 of 24,158) with videos related to

Sort By:
Pageof 2,416
ACS Medicinal Chemistry Letters|November 20, 2024
Bicyclic Ureas as JAK2 Inhibitors for Treating Hematological CancerRam W Sabnis
ACS Medicinal Chemistry Letters|November 20, 2024
Novel Papain-Like Protease Inhibitors for Treating Viral Infections, in Particular Coronavirus InfectionsRam W Sabnis
ACS Medicinal Chemistry Letters|November 20, 2024
Novel Indazole Compounds as PKMYT1 Kinase Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|August 14, 2024
Novel Glucagon-like Peptide 1 Receptor Agonists for Treating Type II DiabetesRam W Sabnis
ACS Medicinal Chemistry Letters|May 15, 2024
Pyrrolidinone Derivatives as NIK Inhibitors for Treating Autoimmune and Inflammatory DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|May 15, 2024
Novel CD73 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|December 18, 2024
Novel Pyrrolidinone Urea Compounds as FPR2 Agonists for Treating Atherosclerosis and Heart FailureRam W Sabnis
ACS Medicinal Chemistry Letters|December 18, 2024
Novel Triazines as NLRP3 Inhibitors for Treating Multiple DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|January 15, 2025
Novel Bicyclic Heterocyclic Compounds as CD73 Inhibitors for Treating CancerRam W Sabnis
ACS Medicinal Chemistry Letters|January 15, 2025
Novel 3-Pyrrolidineindole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis and Mental Illnesses Such as Depression and Post-Traumatic Stress DisorderRam W Sabnis
Pageof 2,416